Narjust Florez, Co-Director of Young Lung Cancer Program at Dana-Farber Cancer Institute, shared a post on X:
“New advances are reshaping early-stage lung cancer care.
A recent review in the Journal of the National Comprehensive Cancer Network highlights a shift toward personalized treatment, combining surgery with immunotherapy and chemotherapy.”
Title: Updates on the Perioperative Management of Resectable Non–Small Cell Lung Cancer
Authors: Stacey M. Frumm, Narjust Florez, Jay M. Lee, Julia K. Rotow, Jamie E. Chaft
Read the Full Article.
